These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 32981382)

  • 1. Design, synthesis, and evaluation of novel
    Huan LC; Anh DT; Hai PT; Anh LD; Park EJ; Ji AY; Kang JS; Dung DTM; Oanh DTK; Tung TT; Hai DTT; Han SB; Nam NH
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):1854-1865. PubMed ID: 32981382
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, Synthesis and Evaluation of Novel (E)-N'-((1-(4-chlorobenzyl)-1H-indol-3-yl)methylene)-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as Antitumor Agents.
    Dung DTM; Park EJ; Anh DT; Hai PT; Bao LQ; Ji AY; Kang JS; Tung TT; Han SB; Nam NH
    Anticancer Agents Med Chem; 2022; 22(14):2586-2598. PubMed ID: 35040418
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel 3,4-dihydro-4-oxoquinazoline-based acetohydrazides: Design, synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
    Huan LC; Tran PT; Phuong CV; Duc PH; Anh DT; Hai PT; Huong LTT; Thuan NT; Lee HJ; Park EJ; Kang JS; Linh NP; Hieu TT; Oanh DTK; Han SB; Nam NH
    Bioorg Chem; 2019 Nov; 92():103202. PubMed ID: 31479984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. (E)-N'-Arylidene-2-(4-oxoquinazolin-4(3H)-yl) acetohydrazides: Synthesis and evaluation of antitumor cytotoxicity and caspase activation activity.
    Huan LC; Phuong CV; Truc LC; Thanh VN; Pham-The H; Huong LT; Thuan NT; Park EJ; Ji AY; Kang JS; Han SB; Tran PT; Nam NH
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):465-478. PubMed ID: 30734614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. New Acetohydrazides Incorporating 2-Oxoindoline and 4-Oxoquinazoline: Synthesis and Evaluation of Cytotoxicity and Caspase Activation Activity.
    Huan LC; Anh DT; Truong BX; Duc PH; Hai PT; Duc-Anh L; Huong LT; Park EJ; Lee HJ; Kang JS; Tran PT; Thanh Hai DT; Kim Oanh DT; Han SB; Nam NH
    Chem Biodivers; 2020 Mar; 17(3):e1900670. PubMed ID: 31943757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design, synthesis and evaluation of novel 2-oxoindoline-based acetohydrazides as antitumor agents.
    Dung DTM; Park EJ; Anh DT; Phan DTP; Na IH; Kwon JH; Kang JS; Tung TT; Han SB; Nam NH
    Sci Rep; 2022 Feb; 12(1):2886. PubMed ID: 35190616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, synthesis, and evaluation of novel (E)-N'-(3-allyl-2-hydroxy)benzylidene-2-(4-oxoquinazolin-3(4H)-yl)acetohydrazides as antitumor agents.
    Dung DTM; Park EJ; Anh DT; Hai PT; Huy LD; Jun HW; Kwon JH; Young Ji A; Kang JS; Tung TT; Dung PTP; Han SB; Nam NH
    Arch Pharm (Weinheim); 2022 Jan; 355(1):e2100216. PubMed ID: 34674294
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N'-[(E)-Arylidene]-2-(2,3-dihydro-3-oxo-4H-1,4-benzoxazin-4-yl)-acetohydrazides: Synthesis and Evaluation of Caspase Activation Activity and Cytotoxicity.
    Huan LC; Truc LC; Phuong CV; Hai PT; Huong LT; Linh NTP; Thuan NT; Park EJ; Choi YJ; Kang JS; Han SB; Nam NH; Tran PT
    Chem Biodivers; 2018 Oct; 15(10):e1800322. PubMed ID: 30054973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
    Kazan F; Yagci ZB; Bai R; Ozkirimli E; Hamel E; Ozkirimli S
    Comput Biol Chem; 2019 Jun; 80():512-523. PubMed ID: 31185422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, pharmacological screening and computational analysis of some 2-(1H-Indol-3-yl)-N'-[(un)substituted phenylmethylidene] acetohydrazides and 2-(1H-Indol-3-yl)-N'-[(un)substituted benzoyl/2-thienylcarbonyl]acetohydrazides.
    Rubab K; Abbasi MA; Rehman A; Siddiqui SZ; Shah SAA; Ashraf M; Ain Q; Ahmad I; Lodhi MA; Ghufran M; Shahid M; Fatima H
    Pak J Pharm Sci; 2017 Jul; 30(4):1263-1274. PubMed ID: 29039324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Design and synthesis of novel isatin-based derivatives targeting cell cycle checkpoint pathways as potential anticancer agents.
    Yousef MA; Ali AM; El-Sayed WM; Qayed WS; Farag HHA; Aboul-Fadl T
    Bioorg Chem; 2020 Dec; 105():104366. PubMed ID: 33212312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quinazoline-Based Hydroxamic Acids: Design, Synthesis, and Evaluation of Histone Deacetylase Inhibitory Effects and Cytotoxicity.
    Hieu DT; Anh DT; Hai PT; Huong LT; Park EJ; Choi JE; Kang JS; Dung PTP; Han SB; Nam NH
    Chem Biodivers; 2018 Jun; 15(6):e1800027. PubMed ID: 29667768
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery of substituted N'-(2-oxoindolin-3-ylidene)benzohydrazides as new apoptosis inducers using a cell- and caspase-based HTS assay.
    Sirisoma N; Pervin A; Drewe J; Tseng B; Cai SX
    Bioorg Med Chem Lett; 2009 May; 19(10):2710-3. PubMed ID: 19369076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and anticancer potential of certain novel 2-oxo-N'-(2-oxoindolin-3-ylidene)-2H-chromene-3-carbohydrazides.
    Abdel-Aziz HA; Elsaman T; Al-Dhfyan A; Attia MI; Al-Rashood KA; Al-Obaid AR
    Eur J Med Chem; 2013; 70():358-63. PubMed ID: 24177362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis and Bioevaluation of Two Series of 3-[(1-Benzyl-1H-1,2,3-triazol-4-yl)methyl]quinazolin-4(3H)-ones and N-(1-Benzylpiperidin-4-yl)quinazolin-4-amines.
    Lan TT; Anh DT; Pham-The H; Dung DTM; Park EJ; Jang SD; Kwon JH; Kang JS; Thuan NT; Han SB; Nam NH
    Chem Biodivers; 2020 Jul; 17(7):e2000290. PubMed ID: 32356584
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of 2-oindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells.
    Eldehna WM; Abo-Ashour MF; Al-Warhi T; Al-Rashood ST; Alharbi A; Ayyad RR; Al-Khayal K; Abdulla M; Abdel-Aziz HA; Ahmad R; El-Haggar R
    J Enzyme Inhib Med Chem; 2021 Dec; 36(1):319-328. PubMed ID: 33345633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and in vitro anticancer evaluation of some 4,6-diamino-1,3,5-triazine-2-carbohydrazides as Rad6 ubiquitin conjugating enzyme inhibitors.
    Kothayer H; Spencer SM; Tripathi K; Westwell AD; Palle K
    Bioorg Med Chem Lett; 2016 Apr; 26(8):2030-4. PubMed ID: 26965855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, molecular docking and biological activity evaluation of some novel indole derivatives as potent anticancer active agents and apoptosis inducers.
    El-Sharief AMS; Ammar YA; Belal A; El-Sharief MAMS; Mohamed YA; Mehany ABM; Elhag Ali GAM; Ragab A
    Bioorg Chem; 2019 Apr; 85():399-412. PubMed ID: 30665034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis, anticancer and apoptosis-inducing activities of quinazoline-isatin conjugates: epidermal growth factor receptor-tyrosine kinase assay and molecular docking studies.
    El-Azab AS; Al-Dhfyan A; Abdel-Aziz AA; Abou-Zeid LA; Alkahtani HM; Al-Obaid AM; Al-Gendy MA
    J Enzyme Inhib Med Chem; 2017 Dec; 32(1):935-944. PubMed ID: 28718672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights.
    Abo-Ashour MF; Eldehna WM; Nocentini A; Bonardi A; Bua S; Ibrahim HS; Elaasser MM; Kryštof V; Jorda R; Gratteri P; Abou-Seri SM; Supuran CT
    Eur J Med Chem; 2019 Dec; 184():111768. PubMed ID: 31629164
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.